R

Revelation Biosciences, Inc. Common StockREVB

Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including the treatment of chronic kidney disease, prevention for post-surgical infection and as a treatment for acute kidney.

US StocksHealthcareSmall CapBiotechnology

REVB Price Trend

Revelation Biosciences, Inc. Common Stock · Full TradingView Chart

NASDAQ:REVB

Onchain Activity